Risk of preeclampsia and other pregnancy complications in frozen single euploid embryo transfers after natural versus artificial endometrial preparation: A truncated randomized controlled trial
José Bellver , Ana Del Arco , Antonio Pellicer , Laura Caracena , Vicente Serra , Elena Labarta , Gemma Castillón , Gemma Fernández , Ana Barrio , Israel Ortega , Iria Fernández , Margarita Torres , Agustín Ballesteros , Elkin Muñoz , Javier Marqueta , Marcos Ferrando , Ángel Grañeras , José Luis Bartha , Nicolás Garrido , Juan Antonio García-Velasco
{"title":"Risk of preeclampsia and other pregnancy complications in frozen single euploid embryo transfers after natural versus artificial endometrial preparation: A truncated randomized controlled trial","authors":"José Bellver , Ana Del Arco , Antonio Pellicer , Laura Caracena , Vicente Serra , Elena Labarta , Gemma Castillón , Gemma Fernández , Ana Barrio , Israel Ortega , Iria Fernández , Margarita Torres , Agustín Ballesteros , Elkin Muñoz , Javier Marqueta , Marcos Ferrando , Ángel Grañeras , José Luis Bartha , Nicolás Garrido , Juan Antonio García-Velasco","doi":"10.1016/j.placenta.2025.02.016","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>To determine for the first time the incidence of preeclampsia and other pregnancy complications according to the mode of endometrial preparation for frozen embryo transfer (FET) in a randomized fashion.</div></div><div><h3>Methods</h3><div>Women about to undergo FET of a single euploid blastocyst were randomly assigned to a modified natural cycle (MNC) or an artificial cycle (AC). Inclusion criteria were as follows: Caucasian; non-obese; 18–43 years of age; nulliparity; regular menstrual cycles; and autologous oocytes. Exclusion criteria were as follows: uterine alterations; moderate-heavy smokers; gamete donation; and chronic diseases. A pilot sub-study of first-trimester markers of preeclampsia was performed in 60 of the patients.</div></div><div><h3>Results</h3><div>Of the 1260 patients estimated, 591 met the inclusion criteria and were willing to participate; of these, 306 and 285 were randomly assigned to a MNC or AC, respectively. After exclusion, 242 and 227 patients finally underwent a MNC or AC, resulting in 131 and 103 clinical pregnancies, 121 and 92 live births, and 91 and 70 questionnaires obtained concerning pregnancy complications, respectively. The incidence of preeclampsia was double in the AC group (10.00 % versus 4.39 %), though not significantly different. In the AC group, the prevalence of first trimester bleeding was significantly higher (42.85 % versus 15.38 %), and there was a significant reduction in live birth rates (40.53 % versus 50.00 %) in the per protocol analysis. No differences in early markers of preeclampsia were detected between the two groups.</div></div><div><h3>Discussion</h3><div>Although this randomized study was truncated, our findings are in accordance with previous reports of a higher risk of preeclampsia and other complications when the endometrium is artificially prepared for FET.</div></div>","PeriodicalId":20203,"journal":{"name":"Placenta","volume":"163 ","pages":"Pages 1-7"},"PeriodicalIF":2.5000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Placenta","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S014340042500058X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/25 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"DEVELOPMENTAL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
To determine for the first time the incidence of preeclampsia and other pregnancy complications according to the mode of endometrial preparation for frozen embryo transfer (FET) in a randomized fashion.
Methods
Women about to undergo FET of a single euploid blastocyst were randomly assigned to a modified natural cycle (MNC) or an artificial cycle (AC). Inclusion criteria were as follows: Caucasian; non-obese; 18–43 years of age; nulliparity; regular menstrual cycles; and autologous oocytes. Exclusion criteria were as follows: uterine alterations; moderate-heavy smokers; gamete donation; and chronic diseases. A pilot sub-study of first-trimester markers of preeclampsia was performed in 60 of the patients.
Results
Of the 1260 patients estimated, 591 met the inclusion criteria and were willing to participate; of these, 306 and 285 were randomly assigned to a MNC or AC, respectively. After exclusion, 242 and 227 patients finally underwent a MNC or AC, resulting in 131 and 103 clinical pregnancies, 121 and 92 live births, and 91 and 70 questionnaires obtained concerning pregnancy complications, respectively. The incidence of preeclampsia was double in the AC group (10.00 % versus 4.39 %), though not significantly different. In the AC group, the prevalence of first trimester bleeding was significantly higher (42.85 % versus 15.38 %), and there was a significant reduction in live birth rates (40.53 % versus 50.00 %) in the per protocol analysis. No differences in early markers of preeclampsia were detected between the two groups.
Discussion
Although this randomized study was truncated, our findings are in accordance with previous reports of a higher risk of preeclampsia and other complications when the endometrium is artificially prepared for FET.
目的:根据冷冻胚胎移植(FET)子宫内膜准备模式,采用随机法首次测定子痫前期及其他妊娠并发症的发生率。方法将拟接受单个整倍体囊胚FET的妇女随机分为改良自然周期(MNC)和人工周期(AC)。纳入标准如下:白种人;非肥胖;18-43岁;未产妇;月经周期规律;自体卵母细胞。排除标准:子宫改变;moderate-heavy吸烟者;配子捐赠;还有慢性病。对60名患者进行了先兆子痫前期标志物的试点亚研究。结果1260例患者中,591例符合纳入标准并愿意参与;其中,306名和285名分别被随机分配到跨国公司或AC。排除后,242例和227例患者最终接受了MNC或AC,分别导致131例和103例临床妊娠,121例和92例活产,并获得了91份和70份关于妊娠并发症的问卷。AC组的先兆子痫发生率为对照组的两倍(10.00% vs 4.39%),但差异无统计学意义。在AC组中,妊娠早期出血的发生率明显更高(42.85%对15.38%),在每个方案分析中,活产率显著降低(40.53%对50.00%)。在子痫前期的早期标记在两组之间没有发现差异。虽然这项随机研究被截断了,但我们的发现与先前的报道一致,即人工准备子宫内膜用于FET时,子痫前期和其他并发症的风险更高。
期刊介绍:
Placenta publishes high-quality original articles and invited topical reviews on all aspects of human and animal placentation, and the interactions between the mother, the placenta and fetal development. Topics covered include evolution, development, genetics and epigenetics, stem cells, metabolism, transport, immunology, pathology, pharmacology, cell and molecular biology, and developmental programming. The Editors welcome studies on implantation and the endometrium, comparative placentation, the uterine and umbilical circulations, the relationship between fetal and placental development, clinical aspects of altered placental development or function, the placental membranes, the influence of paternal factors on placental development or function, and the assessment of biomarkers of placental disorders.